Anmelden

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be formed. Glucuronidation occurs at the luminal side of the endoplasmic reticulum. This process requires an activated endogenous cofactor, which transfers glucuronic acid to the substrate's reactive functional group. The enzyme responsible for facilitating this transfer is UDP-glucuronyl transferase. The resulting metabolites have high molecular weights and are typically excreted through bile. Sulfation, on the other hand, takes place within the cytosol of the cell. This reaction involves the formation of an active endogenous cofactor called phosphoadenosyl phosphosulfate (PAPS). PAPS transfers a sulfate group to the substrate's reactive site in the presence of the sulfotransferase enzyme.

Tags

Drug MetabolismPhase II ReactionsDetoxificationConjugationHydrophilic Drug ConjugatesSulfationGlucuronidationBiologically Inactive MetabolitesProdrugsUDP glucuronyl TransferaseBile ExcretionPhosphoadenosyl Phosphosulfate PAPSSulfotransferase Enzyme

Aus Kapitel 3:

article

Now Playing

3.18 : Drug Metabolism: Phase II Reactions

Pharmacokinetics

3.3K Ansichten

article

3.1 : Pharmakokinetik: Überblick

Pharmacokinetics

4.7K Ansichten

article

3.2 : Absorptionsmechanismus von Medikamenten: Passiver Membrantransport

Pharmacokinetics

3.2K Ansichten

article

3.3 : Absorptionsmechanismus von Medikamenten: Trägervermittelter Membrantransport

Pharmacokinetics

3.2K Ansichten

article

3.4 : Arzneimittelabsorption: Faktoren, die die gastrointestinale Absorption beeinflussen

Pharmacokinetics

3.4K Ansichten

article

3.5 : Bioverfügbarkeit: Überblick

Pharmacokinetics

2.3K Ansichten

article

3.6 : Faktoren, die die Bioverfügbarkeit beeinflussen: First-Pass-Eliminierung

Pharmacokinetics

5.7K Ansichten

article

3.7 : Bioäquivalenz: Überblick

Pharmacokinetics

849 Ansichten

article

3.8 : Effekt "Erster Durchgang"

Pharmacokinetics

4.7K Ansichten

article

3.9 : Zeitverlauf der Arzneimittelwirkung

Pharmacokinetics

1.8K Ansichten

article

3.10 : Wirkstoffverteilung: Gewebebindung

Pharmacokinetics

2.3K Ansichten

article

3.11 : Physiologische Barrieren

Pharmacokinetics

3.2K Ansichten

article

3.12 : Wirkstoffverteilung: Plasmaproteinbindung

Pharmacokinetics

3.9K Ansichten

article

3.13 : Fächermodelle: Modell mit nur einem Fach

Pharmacokinetics

1.9K Ansichten

article

3.14 : Fächermodelle: Modell mit zwei Fächern

Pharmacokinetics

4.8K Ansichten

See More

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten